Karthikeyan Murugesan

17PUBLICATIONS
91CO-AUTHORS
Molecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.

Leah Stein, Karthikeyan Murugesan, Julie W Reeser

|Mar 28, 2024
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma.

Shalini Makawita, Sunyoung Lee, Elisabeth Kong

|Feb 23, 2024
Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal Cancer.

Arndt Vogel, Karthikeyan Murugesan, Gajanan Kendre

|Jan 31, 2024
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment.

Alessandro Russo, Jessica K Lee, Lincoln W Pasquina

Pageof 3